United States · FDA National Drug Code directory
SPIRONOLACTONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17856-1133_59f7927f-899d-3af9-e063-6394a90aacbd
- Product NDC
- 17856-1133
- Form
- SUSPENSION
- Composition / generic term
- spironolactone
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20231031
- Source listing expiry
- 20271231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 BAG (17856-1133-1) / 2.5 mL in 1 SYRINGE (17856-1133-3) · 17856-1133-1
- 1 SYRINGE in 1 BAG (17856-1133-4) / 2.5 mL in 1 SYRINGE (17856-1133-2) · 17856-1133-4
- 120 SYRINGE in 1 CASE (17856-1133-5) / 1 mL in 1 SYRINGE · 17856-1133-5
- 120 SYRINGE in 1 CASE (17856-1133-6) / 3 mL in 1 SYRINGE · 17856-1133-6
- 1 SYRINGE in 1 BAG (17856-1133-7) / 1 mL in 1 SYRINGE · 17856-1133-7
- 1 SYRINGE in 1 BAG (17856-1133-8) / 3 mL in 1 SYRINGE · 17856-1133-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →